Portage Biotech Inc. (NASDAQ:PRTG – Get Free Report) saw a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 14,000 shares, a decline of 74.5% from the June 15th total of 54,900 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 732,100 shares, the days-to-cover ratio is presently 0.0 days.
Portage Biotech Price Performance
Shares of NASDAQ:PRTG remained flat at $0.18 during midday trading on Friday. The stock had a trading volume of 562,441 shares, compared to its average volume of 398,872. Portage Biotech has a 52-week low of $0.13 and a 52-week high of $3.60. The business has a 50-day simple moving average of $0.25 and a two-hundred day simple moving average of $0.55. The firm has a market cap of $3.19 million, a P/E ratio of -0.02 and a beta of 1.47. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.78 and a current ratio of 2.78.
Portage Biotech Company Profile
Featured Articles
- Five stocks we like better than Portage Biotech
- Why is the Ex-Dividend Date Significant to Investors?
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- How to Invest in Insurance Companies: A GuideĀ
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Profitably Trade Stocks at 52-Week Highs
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Portage Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Portage Biotech and related companies with MarketBeat.com's FREE daily email newsletter.